Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

505
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
505
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

817
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
817
Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers01:22

Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers

954
α-Adrenergic antagonists, known as α-blockers, exert their effects by inhibiting α-adrenoceptors, leading to specific physiological actions. α1-blockers and α2-blockers have distinct pharmacological actions and therapeutic applications.
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...
954
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

23
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
23
Adrenergic Antagonists: ɑ and β-Receptor Blockers01:31

Adrenergic Antagonists: ɑ and β-Receptor Blockers

591
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...
591
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

39
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
39

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

BAIBA attenuates pulmonary fibrosis by modulating the iron/ROS-mitochondrion-apoptosis cascade.

Free radical biology & medicine·2026
Same author

Exploring the factors associated with stress coping in individuals with mild cognitive impairment: a qualitative study.

Aging & mental health·2026
Same author

Clinical and CT/MRI features of hepatic AL amyloidosis: preliminary experience in 10 cases.

Frontiers in oncology·2026
Same author

A Kazal-type serine protease inhibitor PaSpink1 from silver pomfret (Pampus argenteus): antibacterial activity and protection against Vibrio parahaemolyticus-induced hepatocyte apoptosis.

International journal of biological macromolecules·2026
Same author

Trajectory optimization for wall-building robots in accordance with nonlinear viscoelastic cement mortar environment.

Scientific reports·2026
Same author

Alanine-mediated crystal facet engineering of β-MnO<sub>2</sub>: Dominant (110) facet for enhanced peroxymonosulfate activation and dimethyl phthalate degradation.

Journal of environmental management·2026

相关实验视频

Updated: Sep 8, 2025

A Novel Method: Super-selective Adrenal Venous Sampling
06:08

A Novel Method: Super-selective Adrenal Venous Sampling

Published on: September 15, 2017

23.6K

从二进制到梯度:EUS-RFA重新定义了初级阿尔多斯顿主义疗法.

Zhixin Xu1, Jing Chang2

  • 1Department of Cardiovascular Medicine, Cardiovascular Research Center, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.

Hypertension research : official journal of the Japanese Society of Hypertension
|July 27, 2025
PubMed
概括

以内式超声波引导的射频剥离 (EUS-RFA) 为胰腺剥离 (PA) 治疗提供了一种新的梯度方法. EUS-RFA显示出有希望的缓解率,为传统医疗或手术干预提供了替代方案.

关键词:
数字高血压是一个数字高血压.实施的高血压.早晨高血压是什么意思主要的阿尔多斯特主义.

更多相关视频

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
12:45

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing

Published on: December 11, 2017

10.6K
Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension
04:37

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension

Published on: June 6, 2025

311

相关实验视频

Last Updated: Sep 8, 2025

A Novel Method: Super-selective Adrenal Venous Sampling
06:08

A Novel Method: Super-selective Adrenal Venous Sampling

Published on: September 15, 2017

23.6K
Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
12:45

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing

Published on: December 11, 2017

10.6K
Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension
04:37

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension

Published on: June 6, 2025

311

科学领域:

  • 胃肠病学和肝病学
  • 干预性内镜检查是干预性的内镜检查.
  • 在瘤学瘤学.

背景情况:

  • 胰腺切除 (PA) 治疗传统上依赖于一种二元方法:手术或药物.
  • 越来越多地探索最小侵入性技术,以改善PA治疗结果和患者康复.
  • 透视式超声波导向的射频剥离 (EUS-RFA) 已成为一种新的治疗选择.

研究的目的:

  • 评估EUS-RFA作为胰腺疾病治疗方式的疗效.
  • 为了比较EUS-RFA的结果与已建立的医学和外科治疗PA.
  • 引入PA治疗的梯度范式,将切除与药物和手术相结合.

主要方法:

  • 在FABULAS试验中,研究了EUS-RFA在肺炎治疗中的结果.
  • 来自医疗治疗 (PAMO标准) 和手术治疗 (PASO标准) 的数据用于比较分析.
  • 生物化学和临床缓解率是主要结果指标.

主要成果:

  • EUS-RFA实现了75%的生化缓解和43%的临床缓解.
  • 医学治疗显示了52.9%的生化反应和18.3%的临床反应.
  • 手术干预产生的最高率:94%的生化缓解和84%的临床缓解.

结论:

  • EUS-RFA代表了一项重大进步,为PA建立了一个梯度处理范式.
  • 虽然没有超过手术,但EUS-RFA提供了一个可行的,不那么侵入性的替代方案,具有显著的缓解率.
  • 这种方法扩大了治疗选择,有可能改善患者管理和PA的结果.